ZUG, Switzerland -- Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedi-cated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced ...
from Content Keyword RSS http://ift.tt/1BKuCWz
via IFTTT
from Content Keyword RSS http://ift.tt/1BKuCWz
via IFTTT
No comments:
Post a Comment